design for health glutathione with Cofactors Glutathione New - Energy Health

Development and optimisation of alternative methods and approaches Main gaps identified: high rate of misleading/false genotoxic positives Existing in vitro methods, whilst having a high sensitivity (and thus low false negative rate), have a relatively low specificity and thus high rate of false (misleading) positive results, which typically has led to unnecessary follow-up testing in vivo for the confirmation of these results

It is backed by ISO 17025-accredited third-party testing and NSF-certified manufacturing

ISRN Pharmacol 2013;2013:147238

One study showed that giving intravenous glutathione helped with symptoms like tremors and stiffness